Ravenel Boykin Curry IV
Eagle Capital Management
Eagle Capital Management GE HealthCare Technologies Inc stake
total: 177
Eagle Capital Management GEHC trades
- Total transactions:
- 7
- New positions:
- 1
- Reduced:
- 6
- Held since:
- 2023 Q1
- Held for:
- 14 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Eagle Capital Management holds 10,970 GE HealthCare Technologies Inc (GEHC) shares with a market value of roughly $702.19K accounting for 0.00% of the overall portfolio. To date, the estimated cost basis is nearly $82.03 for "buy" trades and estimated average "sell" price is $79.88. Eagle Capital Management first purchased GEHC in 2023 Q1, initially acquiring 22,915 shares. Since the initial investment in GE HealthCare Technologies Inc (GEHC), Eagle Capital Management has made 6 more transactions.
When did Eagle Capital Management buy GE HealthCare Technologies Inc (GEHC)?
Eagle Capital Management first invested in GE HealthCare Technologies Inc (GEHC) in 2023 Q1 at the reported quarter-end price of $82.03 per share.
What's the cost basis of Eagle Capital Management's GEHC stake?
The estimated cost basis for GE HealthCare Technologies Inc (GEHC) stake is around $82.03 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $82.03
- Weighted AVG sell price:
- $79.88
Eagle Capital Management's historical trades in GE HealthCare Technologies Inc
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
10,970
|
$64.01
|
$702,190
|
-9.01% (-1,086)
|
-0%
|
|
2025 Q4
|
0.00%
|
12,056
|
$82.02
|
$988,833
|
-0.65% (-79)
|
-0%
|
|
2025 Q1
|
0.00%
|
12,135
|
$80.71
|
$979,416
|
-27.62% (-4,631)
|
-0%
|
|
2024 Q3
|
0.01%
|
16,766
|
$93.85
|
$1,573,489
|
-12.98% (-2,500)
|
-0%
|
|
2023 Q3
|
0.01%
|
19,266
|
$68.04
|
$1,310,859
|
-9.50% (-2,022)
|
-0%
|
|
2023 Q2
|
0.01%
|
21,288
|
$81.24
|
$1,729,437
|
-7.10% (-1,627)
|
-0%
|
|
2023 Q1
|
0.01%
|
22,915
|
$82.03
|
$1,879,717
|
new
|
+0.01%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.